Article

SLT without gonioscopy lens successful

Selective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.

Orlando-Selective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.

Dr. Belkin, of the Goldschleger Eye Research Institute, Tel-Aviv University, Tel-Hashomer, Israel, highlighted his results during a session on glaucoma surgery, wound healing, and lasers at the 2014 meeting of the Association for Research in Vision and Ophthalmology.

In his study, a control group of 16 patients had conventional SLT with 100 laser spots through a gonioscope for 360° directly on the trabecular meshwork. A trial group had irridation performed by the same laser and with the same irridation parameters but without the gonioscope. All surgeries were performed by the same surgeon, Dr. Belkin said.

 

Patients did not have a change in their topical glaucoma therapy during the 6-month study period.

In the trial group, the average IOP decreased from 20.21 to 15.50 mm Hg at 6 months. In the control group, the IOP at 6 months dropped from 21.14 to 15 mm Hg. The IOP reduction difference between the two groups was not statistically significant, Dr. Belkin noted.

The control group had significantly higher complications as well as higher anterior chamber inflammation and superficial punctate keratitis rates.

“You don’t need the gonioscopy lens to do SLT,” Dr. Belkin said. “Transscleral SLT is as efficacious as traditional SLT and it lowers corneal- and gonioscopy-induced side effects.”

Eliminating the use of the gonioscope in SLT could provide wider access to the procedure among physicians, Dr. Belkin said.

 

Additionally, although there is not yet research to support it, SLT without use of a gonioscope may open a treatment avenue for angle-closure glaucoma, he added.

 

For more articles in this issue of Ophthalmology Times’ Conference Brief, click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.